|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Development of a Poly(D,L-lactic-co-glycolic acid)Nanoparticle formulation of STAT3 inhibitor JSI-124:implication for cancer immunotherapy 显示文摘 | Molavi O Mahmud A Hamdy S | 2010 | Mol Pharmaceutics2010，7，2： | 1 |
| 2 | Immunomodulatory and anti- cancer effects of intra-tumoral co-delivery of synthetic lipid a ad iuvant and STAT3 inhibitor, JSI-124显示文摘 | Molavi O Ma Z Hamdy S | 2009 | Immunopharmaeol Immunotoxicol2009，31，2： | 1 |
| 3 | Development of a poly (D,L-lactic-co-glycolic acid) nanoparticle formulation of STAT3 inhibitor JSI-124:implication for cancerimmunotherapy显示文摘 | Molavi O Mahmud A Hamdy S | | 0，，02： | 1 |
| 4 | Resveratrol analog trans 3,4,5,4'-tetramethox- ystilbene ( DMU - 212 ) mediates anti - tumor effects via mechanism different from that of res- veratrol 显示文摘 | Ma Z Molavi O Haddadi A Lai R | 2008 | Cancer Chemother Phannacol2008，63，： | 1 |
| 5 | Gene methylation and silencing of SOCS3 in mantle cell lymphoma显示文摘 | Molavi O Wang P Zak Z | | 0，，： | 1 |
| 6 | Anti-CD30 antibody conjugated liposomal doxorubicin with significantly improved therapeutic efficacy against anaplastic large cell lymphoma 显示文摘 | Molavi O Xiong Xiao-bing Douglas D | 2013 | Biomaterials2013，34，34： | 1 |
| 7 | Micelles of poly (ethylene oxide)-b-poly (e-caprolactone) as vehicles for the solubilization, stabilization, and controlled delivery of curcumin显示文摘 | Ma Z Haddadi A Molavi O | 2008 | Journal of Biomedical Materials Research Part A2008，86，2： | 1 |
| 8 | Micelles of poly(ethylene oxide)-b-poly (epsilon-caprolactone) as vehicles for the solubilization, stabilization, and controlled delivery of eurcumin显示文摘 | Ma Z Haddadi A Molavi O | 2008 | J Biomed Mater Res A2008，86，2： | 1 |
| 9 | Gene methylation and silencing of SOCS3 in mantle cell lymphoma显示文摘 | Molavi O Wang P Zak Z | 2013 | Br J Haematol2013，161，3： | 1 |
| 10 | Synergistic antitumor effects of CpG oligodeoxynucleotide and STAT3 inhibitory agent JSI-124 in a mouse melanoma tumor model 显示文摘 | Molavi O Ma Z Hamdy S | 2008 | Immunol Cell Biol2008，86，6： | 1 |
| 11 | Polymeric micelles for the solubilization and delivery of STAT3 inhibitor cucurbitacins in solid tumors显示文摘 | Molavi O Ma Z S Mahmud A | 2008 | Int J Pharm2008，347，： | 1 |
| 12 | Ef- fective down-regulation of signal transducer and activator of transcription 3 (STAT3) by polyplexes of siRNA and lipid- substituted polyethyleneimine for sensitization of breast tu- mor cells to conventional chemotherapy显示文摘 | Falamarzian A Montazeri Aliabadi I-I Molavi O | 2014 | J Biomed Mater Res A2014，102，9： | 1 |
| 13 | Amphiphilic block co-polymers:Preparation and application in nanodrug and gene delivery显示文摘 | Xiong X B Binkhathlan Z Molavi O | 2012 | Acta Biomaterialia2012，8，： | 1 |
| 14 | Development of a poly(d,l-lactic-co-glycolic acid) nanoparticle formula- tion of STAT3 inhibitor JSI-124:implication for cancer immunotherapy显示文摘 | Molavi O Mahmud A Hamdy S | 2010 | Mol Pharmaceutics2010，7，2： | 1 |
| 15 | Gene methylation and silencing of SOCS3 in mantle cell lymphoma显示文摘 | Molavi O Wang P Zak Z J | 2013 | Br J Haemato2013，161，3： | 1 |
| 16 | Polymeric micelles for the solubilization and delivery of STAT3 inhibitor cucurbitacins in solid tumors显示文摘 | Molavi O Ma Z Mahmud A | 2008 | Int J Pharm2008，347，12： | 1 |
| 17 | Effective down-regualtion of signal transducer and activator of transcription 3 (STAT3) by polyplexes of siRNA and lipid-substituted polyethyleneimine for sensitization of breast tumor cells to conventional chemotherapy 显示文摘 | FALAMARZIAN A ALIABADI H M MOLAVI O | 2014 | J Biomed Mater Res A2014，102，9： | 1 |
| 18 | Development of a poly (d, 1-1actic-co-glycolic acid) nanoparticle formulation of STAT3 inhibitor JSI-124: implication for cancer immunotherapy显示文摘 | Molavi O Mahmud A Hamdy S | 2010 | Mol Pharm2010，7，2： | 1 |
| 19 | Gene methylation and silencing ofSOCS3 in mantle cell lymphoma 显示文摘 | Molavi O Wang P Zak Z | 2013 | BrJ Haematol2013，161，： | 1 |
| 20 | Polymeric micelles for the sol- ubilization and delivery of STAT3 inhibitor cucurbitacins in solid tumors显示文摘 | Molavi O Ma Z Mahmud A | 2008 | Int J Pharm2008，34，12： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员